//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

TIDES: Oligonucleotide and Peptide Therapeutics from Research through Commercialization

CSS

Agenda CSS

The #1 Industry Forum for CMC, Clinical and Discovery Scientists to Accelerate Product Development

May 03-06, 2015
Town and Country Resort
San Diego, CA

Event Overview

Event Overview

Complete Coverage of Oligonucleotides and Peptides

Discovery, Preclinical and Clinical > Chemistry, Manufacturing and Controls >

Coming back to California for the first time since 2006, TIDES 2015 provides you with more in-depth case studies, new data presentations and cutting-edge strategies than ever before to help accelerate your product development. No other conference on the market offers a more comprehensive update on the discovery, clinical development and manufacturing of oligonucleotide and peptide therapeutics.

brochure cover

Complete Brochure Now Available
» Download Today!

» New This Year
» TIDES by the Numbers

Keynotes Provide Success Factors for Drug Development and Manufacturing

Stanley T. Crooke, M.D., Ph.D.

Antisense Technology
Stanley T. Crooke, M.D., Ph.D.
Isis Pharmaceuticals, Inc.

John Maraganore, Ph.D.

RNAi Therapeutics
John Maraganore, Ph.D.
Alnylam Pharmaceuticals

Lene Jessen, Ph.D.

Peptide Therapeutics
Lene Jessen, Ph.D.
Zealand Pharma A/S, Denmark

Kunwar Shailubhai, Ph.D.

Oral Peptide
Kunwar Shailubhai, Ph.D.
Synergy Pharmaceuticals, Inc.

2014 Highlights

2014 Speaker Interviews

Jeffrey Baker, Ph.D.; David C. Blakey, Ph.D.; Jared A. Gollob, M.D.; and Eric von Hofe, Ph.D.

» Watch TIDES 2014 Speaker Interviews

skyline